Evidence map›Paper›PMID 40956163›Full record

GuidelineRadiology2025

Radiologist's Guide to the Ninth Edition TNM Staging System for Quantitative and Qualitative Assessment of Pleural Mesothelioma.

David J Murphy, Anna K Nowak, Thomas Frauenfelder, Michelle S Ginsberg, Hiroshi Kodama, Veronica Lenge de Rosen, Maria Mayoral, Christopher Straus, Giulia Benedetti, Valerie W Rusch and 1 more

Erratum issuedAbstract readPractice GuidelineReview
In one paragraph

Guideline in Radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

David J MurphyDepartment of Radiology, St Vincent's University Hospital and University College Dublin, Dublin, Ireland.ORCID 0000-0002-0361-672X
Anna K NowakNational Centre for Asbestos-Related Diseases, Medical School, University of Western Australia, Crawley, Western Australia, Australia.ORCID 0000-0002-9317-9526
Thomas FrauenfelderInstitute of Diagnostic Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-3295-6619
Michelle S GinsbergDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-0304-110X
Hiroshi KodamaDepartment of Radiology, Hyogo Medical University, Nishinomiya, Japan.
Veronica Lenge de RosenDepartment of Radiology, Baylor College of Medicine, Houston, Tex.ORCID 0000-0001-8200-4256
Maria MayoralDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
Christopher StrausDepartment of Radiology, The University of Chicago, Chicago, Ill.ORCID 0000-0002-4418-1304
Giulia BenedettiDepartment of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.ORCID 0000-0001-6059-112X
Valerie W RuschDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2345-6900
Ritu R GillDepartment of Radiology, Columbia University Columbia University Vagelos College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032.ORCID 0000-0001-8119-8407

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Pleural mesothelioma is a highly lethal, rare thoracic malignant neoplasm arising from mesothelial cells. Previous versions of the clinical TNM staging classification have relied on a qualitative radiologic assessment of tumor invasion. However, these qualitative assessments have not proved practical to implement, with poor interobserver agreement and lack of prognostic significance. The updated ninth edition of the International Association for the Study of Lung Cancer TNM staging system for pleural mesothelioma, jointly published by the American Joint Committee on Cancer and Union for International Cancer Control, proposes key evidence-based changes. The ninth edition incorporates quantitative measurements of pleural tumor and fissural thickness in the T descriptors for pleural mesothelioma and removes the qualitative descriptors that cannot be reliably detected on CT scans, such as endothoracic fascia, lung parenchymal invasion, and nontransmural diaphragm invasion or involvement. This article explains the rationale behind these changes and provides a practical guide to the ninth edition of the TNM staging system in clinical practice.

Indexed as

Mesothelioma, MalignantNeoplasm StagingPleuraGuidelines as TopicHumansLungRadiologistsSocietiesTomography, X-Ray Computed

Identifiers

PMID40956163
PMCPMC12501632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.